NCT06009523 Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
| NCT ID | NCT06009523 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Henri Laborit |
| Condition | Depression and Suicide |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-10-26 |
| Primary Completion | 2027-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-10-26 with a primary completion date of 2027-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this study is to demonstrate that 15 transcranial direct current stimulation (tDCS) sessions of 30 minutes at 2 mA intensity are effective to reduce suicidal ideation
Eligibility Criteria
Inclusion Criteria: * Age over 18 years * Written informed consent * Diagnosis of recurrent or isolated depressive episode according to DSM IV criteria (A.P.A. 1994). * Stable antidepressant treatment for 3 weeks * MADRS score ≥ 20 * SSI score \> 3 * Subject affiliated to a health insurance system * Woman with effective contraception and agreeing to maintain it throughout the study period. Exclusion Criteria: * Depression with psychotic features Axis I (DSM IV) co-morbid diagnosis of schizophrenia, alcohol and/or other substance dependence (or abuse) (lifetime) * Patient who has already undergone an electroconvulsive therapy course for the current episode and does not respond to this treatment * Patient deprived of liberty * Patient with high suicide risk (item 10 MADRS \> 4) in the absence of hospitalization * Contraindication to tDCS: intracerebral metallic implant (with the exception of dental implants), cardiac pacemaker, active or non-implanted devices in the region of the head, acute eczema in the planned stimulation area * Pregnant, parturient or breastfeeding woman * Simultaneous participation in another interventional research
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06009523 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression and Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06009523 currently recruiting?
Yes, NCT06009523 is actively recruiting participants. Contact the research team at ghina.harika-germaneau@ch-poitiers.fr for enrollment information.
Where is the NCT06009523 trial being conducted?
This trial is being conducted at Faye-l'Abbesse, France, Poitiers, France.
Who is sponsoring the NCT06009523 clinical trial?
NCT06009523 is sponsored by Centre Hospitalier Henri Laborit. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.